These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 35491945)

  • 1. CFIm25 regulates human stem cell function independently of its role in mRNA alternative polyadenylation.
    Ran Y; Huang S; Shi J; Feng Q; Deng Y; Xiang AP; Yao C
    RNA Biol; 2022; 19(1):686-702. PubMed ID: 35491945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CFIm25 links alternative polyadenylation to glioblastoma tumour suppression.
    Masamha CP; Xia Z; Yang J; Albrecht TR; Li M; Shyu AB; Li W; Wagner EJ
    Nature; 2014 Jun; 510(7505):412-6. PubMed ID: 24814343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of cleavage factor Im 25 promotes the proliferation of lung cancer cells through alternative polyadenylation.
    Huang J; Weng T; Ko J; Chen NY; Xiang Y; Volcik K; Han L; Blackburn MR; Lu X
    Biochem Biophys Res Commun; 2018 Sep; 503(2):856-862. PubMed ID: 29928883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The emerging roles of CFIm25 (NUDT21/CPSF5) in human biology and disease.
    Masamha CP
    Wiley Interdiscip Rev RNA; 2023; 14(3):e1757. PubMed ID: 35965101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CFIm25 and alternative polyadenylation: Conflicting roles in cancer.
    Jafari Najaf Abadi MH; Shafabakhsh R; Asemi Z; Mirzaei HR; Sahebnasagh R; Mirzaei H; Hamblin MR
    Cancer Lett; 2019 Sep; 459():112-121. PubMed ID: 31181319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Cancer-Specific Ubiquitin Ligase Drives mRNA Alternative Polyadenylation by Ubiquitinating the mRNA 3' End Processing Complex.
    Yang SW; Li L; Connelly JP; Porter SN; Kodali K; Gan H; Park JM; Tacer KF; Tillman H; Peng J; Pruett-Miller SM; Li W; Potts PR
    Mol Cell; 2020 Mar; 77(6):1206-1221.e7. PubMed ID: 31980388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implications of polyadenylation in health and disease.
    Curinha A; Oliveira Braz S; Pereira-Castro I; Cruz A; Moreira A
    Nucleus; 2014; 5(6):508-19. PubMed ID: 25484187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of CFIm25 knockout on RNA polymerase II transcription.
    Tellier M; Hardy JG; Norbury CJ; Murphy S
    BMC Res Notes; 2018 Dec; 11(1):894. PubMed ID: 30547832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knock-down of 25 kDa subunit of cleavage factor Im in Hela cells alters alternative polyadenylation within 3'-UTRs.
    Kubo T; Wada T; Yamaguchi Y; Shimizu A; Handa H
    Nucleic Acids Res; 2006; 34(21):6264-71. PubMed ID: 17098938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involved microRNAs in alternative polyadenylation intervene in breast cancer via regulation of cleavage factor "CFIm25".
    Tamaddon M; Shokri G; Hosseini Rad SMA; Rad I; Emami Razavi À; Kouhkan F
    Sci Rep; 2020 Jul; 10(1):11608. PubMed ID: 32665581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Driving glioblastoma growth by alternative polyadenylation.
    Han T; Kim JK
    Cell Res; 2014 Sep; 24(9):1023-4. PubMed ID: 24993033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of CFIm25 amplifies dermal fibrosis through alternative polyadenylation.
    Weng T; Huang J; Wagner EJ; Ko J; Wu M; Wareing NE; Xiang Y; Chen NY; Ji P; Molina JG; Volcik KA; Han L; Mayes MD; Blackburn MR; Assassi S
    J Exp Med; 2020 Feb; 217(2):. PubMed ID: 31757866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CFIm-mediated alternative polyadenylation remodels cellular signaling and miRNA biogenesis.
    Ghosh S; Ataman M; Bak M; Börsch A; Schmidt A; Buczak K; Martin G; Dimitriades B; Herrmann CJ; Kanitz A; Zavolan M
    Nucleic Acids Res; 2022 Apr; 50(6):3096-3114. PubMed ID: 35234914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knockdown of pre-mRNA cleavage factor Im 25 kDa promotes neurite outgrowth.
    Fukumitsu H; Soumiya H; Furukawa S
    Biochem Biophys Res Commun; 2012 Sep; 425(4):848-53. PubMed ID: 22898046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silencing the cleavage factor CFIm25 as a new strategy to control Entamoeba histolytica parasite.
    Ospina-Villa JD; Guillén N; Lopez-Camarillo C; Soto-Sanchez J; Ramirez-Moreno E; Garcia-Vazquez R; Castañon-Sanchez CA; Betanzos A; Marchat LA
    J Microbiol; 2017 Oct; 55(10):783-791. PubMed ID: 28956353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence that cleavage factor Im is a heterotetrameric protein complex controlling alternative polyadenylation.
    Kim S; Yamamoto J; Chen Y; Aida M; Wada T; Handa H; Yamaguchi Y
    Genes Cells; 2010 Sep; 15(9):1003-13. PubMed ID: 20695905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cleavage factor 25 deregulation contributes to pulmonary fibrosis through alternative polyadenylation.
    Weng T; Ko J; Masamha CP; Xia Z; Xiang Y; Chen NY; Molina JG; Collum S; Mertens TC; Luo F; Philip K; Davies J; Huang J; Wilson C; Thandavarayan RA; Bruckner BA; Jyothula SS; Volcik KA; Li L; Han L; Li W; Assassi S; Karmouty-Quintana H; Wagner EJ; Blackburn MR
    J Clin Invest; 2019 May; 129(5):1984-1999. PubMed ID: 30830875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Partial loss of CFIm25 causes learning deficits and aberrant neuronal alternative polyadenylation.
    Alcott CE; Yalamanchili HK; Ji P; van der Heijden ME; Saltzman A; Elrod N; Lin A; Leng M; Bhatt B; Hao S; Wang Q; Saliba A; Tang J; Malovannaya A; Wagner EJ; Liu Z; Zoghbi HY
    Elife; 2020 Apr; 9():. PubMed ID: 32319885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated pre-mRNA 3' end processing activity in cancer cells renders vulnerability to inhibition of cleavage and polyadenylation.
    Cui Y; Wang L; Ding Q; Shin J; Cassel J; Liu Q; Salvino JM; Tian B
    Nat Commun; 2023 Aug; 14(1):4480. PubMed ID: 37528120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fip1 regulates mRNA alternative polyadenylation to promote stem cell self-renewal.
    Lackford B; Yao C; Charles GM; Weng L; Zheng X; Choi EA; Xie X; Wan J; Xing Y; Freudenberg JM; Yang P; Jothi R; Hu G; Shi Y
    EMBO J; 2014 Apr; 33(8):878-89. PubMed ID: 24596251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.